Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioAxial is a French biotechnology company that developed advanced super-resolution microscopy modules for live-cell imaging. The company's flagship technology, Conical Diffraction Microscopy (CODIM), provides high-resolution imaging while minimizing phototoxicity and photobleaching, making it ideal for observing delicate biological processes. BioAxial's products were designed to be integrated into existing confocal microscopes, enhancing their resolution beyond the diffraction limit without requiring specialized fluorophores. In 2021, the company was acquired by Telight, a Czech imaging technology firm, to integrate CODIM into a broader portfolio of quantitative phase imaging solutions. The acquisition aimed to combine BioAxial's super-resolution capabilities with Telight's expertise in light microscopy to advance the field of bioimaging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioAxial.